For all official information and updates regarding COVID-19, please visit the South African Department of Health’s website

Welcome to Medpharm Publications

New eucalytptus & menthol formulation has excellent anti-viral properties

New eucalyptus & menthol formulation has excellent anti-viral properties South African’s are now able to breathe easier with the NEW RespiClear® Decongestant range from OBEL®. The range boasts steroid-free Nebs, petroleum-free Vapour Rub and preservative-free...

Does your sanitiser guarantee your protection against SARS-CoV2?

In what can only be called a ground breaking result, not only for Biodx but also South Africa in the ongoing fight against Coronavirus, Biodx has received the official confirmation from TNO (The Netherlands Organisation for applied scientific research) that our active ingredient b bioactive™, has a 99.987% reduction against the SARS-CoV2 virus for surface disinfection and hand sanitisers.

Supply chain management is the vital ingredient needed for covid-19 vaccine success in South Africa

While President Cyril Ramaphosa has announced that South Africa’s Covid-19 vaccine strategy is well underway, with 20 million doses to be delivered in the first half of the year, this is just the first step, and effective supply chain management will be the key ingredient for a successful vaccine roll-out, according to SAPICS, Southern Africa’s Professional Body for Supply Chain Management.

Mental illness disability in the workplace – the stigma is real

Work is good for your mental health but many employees with mental health-related disability face an uphill battle against discrimination, stigma and ignorance as they strive for equality and full participation in work.
At the same time, employers who fail to offer reasonable accommodation or adapt working conditions or duties for an employee with psychosocial disability can find themselves on the wrong side of the law.

Intercare partners with super app for immediate access to primary healthcare

Tele-medicine is now made possible through smartphone technology to the public through a free super app – just in time for the festive season. This technology enables the private sector to have a stake in digital healthcare in South Africa – a unique opportunity to support this fast-growing need for accessibility to primary healthcare.

Medpharm Publications was founded in 1988 and has established itself as the largest medical and pharmaceutical journal publisher in South Africa.
With a publications list of more than ten titles comprising of over fifty journal editions, Medpharm Publications reach more than 40 000 healthcare workers countrywide with printed editions, and has established a global audience with the online editions.
The majority of Medpharm Publications’ journals are associated with professional or scholarly societies and acts as the official South African mouthpiece in the associated discipline. All journals are web-based, most of which are fully peer-reviewed, with five titles accredited by the South African Department of Higher Education and Training (DHET) to earn research subsidies for academic departments.
As a publisher, passionate about journal publishing, we believe that South African researchers and clinicians can and will make a significant contribution to world medical literature.